Plasmodium falciparum exoprotein stimulation of human T-lymphocytes unsensitized to malaria. 1988

G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
Laboratoire d'Hematologie Expérimentale (CNRS-LP-101), Hôpital St. Louis, Paris, France.

The effects of Plasmodium falciparum proteins released in asexual blood stage culture supernatants on human T-lymphocytes from malaria non-immune donors were examined. Supernatants from several plasmodial strains stimulated both CD+4 and CD+8 T-lymphocytes to proliferate and secrete interferon gamma in vitro. Active moieties were predominantly released during the final stages of the parasite cycle. They were enriched by gel filtration and were further purified by anion-exchange and Superose 12 column fast protein liquid chromatography. Three active fractions of apparent 250, 70 and 18 kilodaltons were identified. The parasitic origin of the predominant 70-kilodaltons protein(s) was shown by biosynthesis experiments with radioactive amino acid precursors and was also demonstrated by in vitro translation of parasitic mRNA species. Interestingly, antibodies to the 70-kilodalton exoprotein(s) also reacted to a schizont protein of similar molecular weight.

UI MeSH Term Description Entries
D007120 Immunochemistry Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D012156 Reticulocytes Immature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic "reticulum" (not the same as the ENDOPLASMIC RETICULUM), hence the name reticulocytes. Reticulocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
April 1979, Infection and immunity,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
May 1987, The Journal of infectious diseases,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
July 1994, Immunology letters,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
December 1985, The EMBO journal,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
April 1991, Proceedings of the National Academy of Sciences of the United States of America,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
November 1989, Journal of clinical microbiology,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
September 1995, Annales de la Societe belge de medecine tropicale,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
September 2019, Science advances,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
July 1990, The Journal of infectious diseases,
G Jaureguiberry, and W Ogunkolade, and E Bailly, and A Rhodes-Feuillette, and M Agrapart, and J J Ballet
October 1976, Nature,
Copied contents to your clipboard!